The MOPED study identified significant variation in perioperative diabetes management and 30-day outcomes across 21 European countries.
Preoperative glycemic control is a key predictor of recovery, with HbA1c levels >69 mmol/mol associated with a significant reduction in Days at Home at 30 Days (DAH-30).
Patients with Type 1 Diabetes (T1DM) were more likely to present with elevated HbA1c levels compared to those with Type 2 Diabetes (T2DM).
The association between glycemic control and outcomes was particularly pronounced in patients undergoing surgeries with minimal blood loss.
Background: The Growing Challenge of Diabetes in Surgery
